Rentokil Initial (RTO) Common Equity (2021 - 2025)

On a quarterly basis, Common Equity rose 1.22% to $5.5 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $5.5 billion, a 1.22% increase, with the full-year FY2025 number at $5.5 billion, up 3.76% from a year prior.

Rentokil Initial (RTO) has 5 years of Common Equity data on record, last reported at $5.5 billion in Q4 2025.

  • Common Equity reached $5.5 billion in Q4 2025 per RTO's latest filing, up from $5.3 billion in the prior quarter.
  • Over the last five years, Common Equity for RTO hit a ceiling of $5.5 billion in Q4 2025 and a floor of $1.7 billion in Q4 2021.
  • A 5-year average of $4.5 billion and a median of $5.1 billion in 2023 define the central range for Common Equity.
  • Peak YoY movement for Common Equity: soared 182.1% in 2022, then rose 0.24% in 2025.
  • Tracing RTO's Common Equity over 5 years: stood at $1.7 billion in 2021, then soared by 182.1% to $4.8 billion in 2022, then grew by 5.56% to $5.1 billion in 2023, then grew by 6.98% to $5.4 billion in 2024, then increased by 1.22% to $5.5 billion in 2025.
  • Business Quant data shows Common Equity for RTO at $5.5 billion in Q4 2025, $5.3 billion in Q2 2025, and $5.4 billion in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Relx 81.40 Bn 81.16 Bn - 3.15 Bn
2 Rentokil Initial 79.56 Bn 78.10 Bn - 5.49 Bn
3 Cintas 69.26 Bn 69.08 Bn 1.45 Bn 4.79 Bn
4 Copart 33.09 Bn 28.01 Bn 971.24 Mn 9.79 Bn
5 UL Solutions 20.56 Bn 20.32 Bn 381.00 Mn 1.32 Bn
6 Global Payments 19.88 Bn 14.69 Bn 1.70 Bn 24.46 Bn
7 Rb Global 19.08 Bn 18.89 Bn 869.50 Mn 5.62 Bn
8 Aramark 13.57 Bn 13.16 Bn 426.35 Mn 3.28 Bn
9 Amentum Holdings 5.65 Bn 5.74 Bn 345.00 Mn 4.70 Bn
10 Dolby Laboratories 5.15 Bn 4.56 Bn 350.90 Mn 2.62 Bn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 5.49 Bn
Jun 30, 2025 5.27 Bn
Dec 31, 2024 5.43 Bn
Jun 30, 2024 5.25 Bn
Dec 31, 2023 5.07 Bn
Jun 30, 2023 4.95 Bn
Dec 31, 2022 4.81 Bn
Jun 30, 2022 2.21 Bn
Dec 31, 2021 1.70 Bn